Skip to content

Clinical trials

Hepatitis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20092
20101
20111
20131
20153
20182
20201
20212
20224
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status6
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Brii Biosciences Limited2
Gilead Sciences2
Novartis Pharmaceuticals2
The First Hospital of Jilin University2
AusperBio Therapeutics Inc.1
Beijing Municipal Administration of Hospitals1
Hexaell Biotech Co., Ltd.1
Institute of Hematology & Blood Diseases Hospital, China1
Nanfang Hospital, Southern Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis23
Hepatitis B9
Hepatitis B, Chronic8
Hepatitis, Chronic4
Liver Diseases4
Digestive System Diseases3
Hepatitis C3
DNA Virus Infections2
Fatty Liver2
Hepatitis A2

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.